Daytrading, Eminis, Forex trading, Swing Trading ASIAN MARKETS - 485910
Sammy King  |  by www.tradingmarkets.com. All rights reserved. 13.11 | 23:23

Receive Dave's best setups each evening from his favorite trading patterns.

Let Gary Kaltbaum send you timely emails to alrt when breakouts occure.
Every day receive the best plan of attack for the next day's trading directly from professional trader Kevin Haggerty.

(RTTNews) - Aurobindo Pharma announced that the company received another marketing authorization approval from Medicines Control Council of South Africa for its Stavudine tablets in 30mg and 40mg strengths. The company by bagging this approval makes further inroads into this market. With Stavudine, the company has five of its ARV's products approved.

Stavudine is an antiviral agent of the nucleoside analog class. The international brand name is Zerit and is marketed by Bristol Myers Squibb. Stavudine is used in combination with other NRTIs and NNRTIs class of drugs in HIV patients.

Stavudine enjoys a market of over $30 million in South Africa.

Read more on by www.tradingmarkets.com. All rights reserved.
Keywords: South Africa
Related news
Post comments
Name
Place
1 + 2 =
Comments